Capricor Therapeutics, Inc.
CAPR
Jodie situation report
CAPR dominates a concentrated Clinical-Stage Biotech move.
CAPR accounts for 53.6% of the group's measured movement across 2.0 effective names. raw member direction is mixed; 1 of 2 session-normalized paths align to the upside. Capital-flow agreement is 38%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
CAPR was the first measured mover. CAPR crossed its material path threshold at 10:00 ET. STRO followed.
2 of 2 members in Clinical-Stage Biotech are active. 1 of 6 disclosed connections are confirming.
- At least 2 of 2 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- EWTX remains aligned with the group in the next market snapshot.
Invalidation: The live read weakens if participation falls to 1 of 2 members or fewer.
Who this business touches
The relationships behind CAPR
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
TMOThermo Fisher Scientific IncsupplierMar 17, 2026 ▾
“13 Table of Contents Cell Line License Agreement with Life Technologies On March 7, 2022, Capricor entered into a non-exclusive cell line license agreement with Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, Inc., for the supply of c…”
OPYOppenheimer Holdings, Inc.partnerNov 10, 2025 ▾
“g under a prospectus supplement for aggregate sales proceeds of up to $150.0 million (the “September 2025 ATM Program”) on September 10, 2025, pursuant to an Equity Distribution Agreement with Piper Sandler and Oppenheimer (collectively, the “Agents”) by whic…”
Depended on by
BCDABioCardia, Inc.competitorMar 24, 2026 ▾
“The industry continues to expand and evolve as an increasing number of competitors and potential competitors enter the market, including AstraZeneca, Bayer, Blue Rock Therapeutics, Bristol-Myers Squibb, Lisata Therapeutics, Capricor Therapeutics, Celixir, Cel…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 5 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
CAPR is currently a Early Follower in the organic co-movement group Clinical-Stage Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.